RECURSION PHARMACEUTICALS, INC.
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
| Total revenue |
0.07 |
0.06 |
0.04 |
0.04 |
0.01 |
0.00 |
0.00 |
| Cost of revenue |
0.12 |
0.05 |
0.04 |
0.05 |
0.01 |
0.06 |
0.05 |
| Gross profit |
-0.05 |
0.01 |
0.00 |
-0.01 |
0.01 |
0.00 |
-0.04 |
| Selling, general and administrative |
0.18 |
0.18 |
0.11 |
0.08 |
0.06 |
0.03 |
0.02 |
| Research and development |
0.43 |
0.31 |
0.24 |
0.16 |
0.14 |
0.06 |
0.05 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.65 |
-0.48 |
-0.35 |
-0.25 |
-0.18 |
-0.08 |
-0.06 |
| Non-operating income (net) |
0.00 |
0.01 |
0.02 |
0.01 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.64 |
-0.46 |
-0.33 |
-0.24 |
-0.19 |
-0.09 |
-0.06 |
| Income tax expense |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
| Net income |
-0.64 |
-0.46 |
-0.33 |
-0.24 |
-0.18 |
-0.09 |
-0.06 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
| Total revenue |
0.01 |
0.04 |
0.01 |
0.02 |
0.01 |
0.00 |
0.03 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Cost of revenue |
0.01 |
0.03 |
0.03 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.01 |
0.01 |
0.00 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
| Gross profit |
-0.01 |
0.01 |
-0.02 |
0.00 |
-0.01 |
-0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
-0.01 |
| Selling, general and administrative |
0.03 |
0.03 |
0.04 |
0.05 |
0.05 |
0.08 |
0.04 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
| Research and development |
0.09 |
0.08 |
0.12 |
0.13 |
0.13 |
0.10 |
0.07 |
0.07 |
0.07 |
0.07 |
0.07 |
0.06 |
0.05 |
0.04 |
0.04 |
0.04 |
0.03 |
0.05 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.13 |
-0.11 |
-0.17 |
-0.18 |
-0.19 |
-0.18 |
-0.10 |
-0.10 |
-0.10 |
-0.10 |
-0.10 |
-0.08 |
-0.07 |
-0.06 |
-0.06 |
-0.07 |
-0.06 |
-0.06 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
| Non-operating income (net) |
0.01 |
0.00 |
0.01 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.12 |
-0.11 |
-0.16 |
-0.17 |
-0.20 |
-0.18 |
-0.10 |
-0.10 |
-0.09 |
-0.10 |
-0.09 |
-0.08 |
-0.07 |
-0.06 |
-0.06 |
-0.07 |
-0.06 |
-0.06 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
| Income tax expense |
0.00 |
0.00 |
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
-0.12 |
-0.11 |
-0.16 |
-0.17 |
-0.20 |
-0.18 |
-0.10 |
-0.10 |
-0.09 |
-0.09 |
-0.09 |
-0.08 |
-0.07 |
-0.06 |
-0.06 |
-0.07 |
-0.06 |
-0.06 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
| Cash and cash equivalents |
0.74 |
0.59 |
0.39 |
0.55 |
0.29 |
0.26 |
0.07 |
| Short-term investments |
|
|
|
0.00 |
0.23 |
0.00 |
|
| Accounts receivable, net |
0.02 |
0.05 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
| Inventories |
|
|
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
| Other current assets |
0.04 |
0.07 |
0.04 |
0.02 |
0.01 |
0.00 |
0.01 |
| Total current assets |
0.81 |
0.71 |
0.44 |
0.57 |
0.53 |
0.27 |
0.08 |
| Property, plant and equipment, net |
|
|
|
0.12 |
0.06 |
0.03 |
0.02 |
| Goodwill |
0.16 |
0.15 |
0.05 |
0.00 |
0.00 |
0.00 |
|
| Intangible assets |
0.31 |
0.34 |
0.04 |
0.00 |
0.00 |
0.00 |
|
| Long-term investments |
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
| Total assets |
1.47 |
1.45 |
0.65 |
0.70 |
0.61 |
0.30 |
0.10 |
|
| Accounts payable |
0.02 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Short-term debt |
0.02 |
0.02 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
| Current portion of long-term debt |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Deferred revenue |
|
|
|
|
|
|
|
| Other current liabilities |
0.07 |
0.08 |
0.05 |
0.03 |
0.03 |
0.01 |
0.00 |
| Long-term debt |
0.01 |
0.02 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
| Capital lease obligations |
0.06 |
0.08 |
0.05 |
0.05 |
0.01 |
0.00 |
0.00 |
| Other non-current liabilities |
0.00 |
0.00 |
|
|
0.02 |
|
|
| Total liabilities |
0.34 |
0.41 |
0.19 |
0.22 |
0.07 |
0.50 |
0.23 |
|
| Common stock and paid-in capital |
3.21 |
2.47 |
1.43 |
1.13 |
0.94 |
0.01 |
0.00 |
| Retained earnings |
-2.08 |
-1.43 |
-0.97 |
-0.64 |
-0.40 |
-0.21 |
-0.13 |
| Common shares outstanding |
447 |
274 |
208 |
176 |
170 |
166 |
166 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
| Cash and cash equivalents |
0.65 |
0.74 |
0.66 |
0.53 |
0.50 |
0.59 |
0.43 |
0.47 |
0.30 |
0.39 |
0.39 |
0.41 |
0.47 |
0.55 |
0.45 |
0.45 |
0.51 |
0.29 |
0.39 |
0.63 |
0.21 |
0.26 |
|
|
-0.07 |
| Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.06 |
0.08 |
0.23 |
0.18 |
|
|
|
|
|
0.14 |
| Accounts receivable, net |
0.01 |
0.02 |
0.02 |
0.02 |
0.05 |
0.05 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Inventories |
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
|
|
|
| Other current assets |
0.04 |
0.04 |
0.03 |
0.04 |
0.04 |
0.07 |
0.04 |
0.05 |
0.04 |
0.04 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.02 |
0.01 |
0.01 |
0.00 |
|
|
|
| Total current assets |
0.71 |
0.81 |
0.71 |
0.59 |
0.58 |
0.71 |
0.47 |
0.52 |
0.34 |
0.44 |
0.41 |
0.43 |
0.49 |
0.57 |
0.48 |
0.55 |
0.62 |
0.53 |
0.60 |
0.65 |
0.22 |
0.27 |
|
|
0.07 |
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
0.09 |
0.09 |
0.12 |
0.09 |
0.08 |
0.07 |
0.06 |
0.06 |
0.05 |
0.04 |
|
|
|
|
| Goodwill |
0.16 |
0.16 |
0.16 |
0.16 |
0.16 |
0.15 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.06 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Intangible assets |
0.29 |
0.31 |
0.32 |
0.34 |
0.34 |
0.34 |
0.03 |
0.04 |
0.03 |
0.04 |
0.04 |
0.04 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
1.34 |
1.47 |
1.40 |
1.30 |
1.31 |
1.45 |
0.73 |
0.78 |
0.56 |
0.65 |
0.63 |
0.67 |
0.63 |
0.70 |
0.61 |
0.67 |
0.73 |
0.61 |
0.66 |
0.70 |
0.27 |
0.30 |
|
|
|
|
| Accounts payable |
0.02 |
0.02 |
0.01 |
0.02 |
0.03 |
0.02 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
|
| Short-term debt |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Current portion of long-term debt |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.05 |
0.07 |
0.07 |
0.08 |
0.06 |
0.08 |
0.04 |
0.03 |
0.03 |
0.05 |
0.04 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.02 |
0.03 |
0.03 |
0.01 |
0.01 |
0.01 |
|
|
|
| Long-term debt |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.02 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
|
|
|
| Capital lease obligations |
0.06 |
0.06 |
0.06 |
0.07 |
0.07 |
0.08 |
0.06 |
0.06 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.05 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Other non-current liabilities |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
0.08 |
0.10 |
|
0.14 |
0.14 |
0.15 |
0.02 |
0.01 |
|
|
|
|
|
|
| Total liabilities |
0.31 |
0.34 |
0.35 |
0.38 |
0.37 |
0.41 |
0.20 |
0.19 |
0.16 |
0.19 |
0.19 |
0.20 |
0.20 |
0.22 |
0.22 |
0.23 |
0.24 |
0.07 |
0.06 |
0.06 |
0.50 |
0.50 |
|
|
|
|
| Common stock and paid-in capital |
3.22 |
3.21 |
3.01 |
2.72 |
2.57 |
2.47 |
1.78 |
1.74 |
1.46 |
1.43 |
1.31 |
1.25 |
1.14 |
1.13 |
0.97 |
0.96 |
0.95 |
0.94 |
0.93 |
0.93 |
0.01 |
0.01 |
0.00 |
0.00 |
0.08 |
| Retained earnings |
-2.19 |
-2.08 |
-1.97 |
-1.81 |
-1.63 |
-1.43 |
-1.25 |
-1.16 |
-1.06 |
-0.97 |
-0.87 |
-0.78 |
-0.70 |
-0.64 |
-0.58 |
-0.52 |
-0.46 |
-0.40 |
-0.34 |
-0.29 |
-0.24 |
-0.21 |
|
|
|
| Common shares outstanding |
529 |
527 |
447 |
417 |
403 |
336 |
283 |
242 |
236 |
233 |
214 |
201 |
192 |
186 |
173 |
172 |
171 |
169 |
169 |
168 |
168 |
167 |
169 |
168 |
168 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
| Net income |
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.08 |
0.04 |
0.02 |
0.01 |
0.01 |
0.00 |
0.00 |
| Stock-based compensation |
0.11 |
0.08 |
0.05 |
0.03 |
0.01 |
0.00 |
0.00 |
| Change in inventory |
|
|
|
0.00 |
0.01 |
0.00 |
|
| Other working capital changes |
-0.57 |
-0.48 |
-0.37 |
-0.12 |
-0.19 |
-0.06 |
-0.06 |
| Capital expenditures |
-0.01 |
-0.01 |
-0.01 |
-0.04 |
-0.04 |
-0.01 |
0.00 |
| Others incl. marketable securities changes |
-0.01 |
0.27 |
0.00 |
0.23 |
-0.23 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
0.47 |
|
|
| Net Debt Issuance |
0.52 |
0.30 |
0.14 |
0.15 |
-0.01 |
0.25 |
0.12 |
|
| Change in cash |
0.13 |
0.21 |
-0.16 |
0.26 |
0.03 |
0.19 |
0.06 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.02 |
0.02 |
0.03 |
0.03 |
0.04 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Change in inventory |
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.01 |
|
|
0.01 |
0.00 |
0.00 |
0.00 |
|
|
|
| Other working capital changes |
-0.12 |
-0.09 |
-0.16 |
-0.13 |
-0.19 |
-0.16 |
-0.08 |
-0.11 |
-0.13 |
-0.10 |
-0.10 |
-0.09 |
-0.09 |
-0.05 |
-0.06 |
-0.08 |
0.07 |
-0.07 |
-0.05 |
-0.04 |
-0.03 |
0.00 |
-0.02 |
-0.02 |
-0.02 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.28 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.06 |
0.02 |
0.15 |
-0.05 |
-0.18 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.46 |
0.00 |
|
|
|
|
| Net Debt Issuance |
0.00 |
0.13 |
0.25 |
0.10 |
0.04 |
0.01 |
0.02 |
0.26 |
0.01 |
0.08 |
0.05 |
0.00 |
0.00 |
0.15 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.01 |
0.23 |
0.00 |
0.01 |
|
| Change in cash |
-0.08 |
0.08 |
0.13 |
0.02 |
-0.10 |
0.17 |
-0.05 |
0.18 |
-0.10 |
0.00 |
-0.02 |
-0.07 |
-0.08 |
0.09 |
0.00 |
-0.05 |
0.22 |
-0.11 |
-0.24 |
0.42 |
-0.05 |
0.01 |
0.21 |
-0.02 |
-0.01 |
RECURSION PHARMACEUTICALS, INC. (RXRX) - Other Non Operating Income
RECURSION PHARMACEUTICALS, INC. (RXRX) - Net Income
RECURSION PHARMACEUTICALS, INC. (RXRX) - Ebitda
RECURSION PHARMACEUTICALS, INC. (RXRX) - Ebit
RECURSION PHARMACEUTICALS, INC. (RXRX) - Net Income From Continuing Operations
RECURSION PHARMACEUTICALS, INC. (RXRX) - Income Tax Expense
RECURSION PHARMACEUTICALS, INC. (RXRX) - Income Before Tax
RECURSION PHARMACEUTICALS, INC. (RXRX) - Depreciation And Amortization
RECURSION PHARMACEUTICALS, INC. (RXRX) - Interest Expense
RECURSION PHARMACEUTICALS, INC. (RXRX) - Interest Income